Do analysts think that Hutchmed (china) is a buy, hold or sell?

Do analysts think that Hutchmed (china) is a buy, hold or sell?

Article image

Trying to predict how the Covid-19 crisis will impact on companies and sectors is not easy. Fortunately, large companies like Hutchmed (china) (LON:HCM) are well covered by professional analysts who are used to making forecasts about them. 

Hutchmed (china) is one of just 200 shares in the UK market valued at more than £1.0 billion (its market cap is £3,449m). Shares like this are closely watched because they have an influential role in the performance of investment funds and pension portfolios held by millions of savers. 

So how have the shares performed over the past year?

On a 12 month basis, the Hutchmed (china) share price has seen an absolute move of -7.64%. On a relative basis - which take into account the movement of the wider market - the shares have moved by -17.9% over the past year and by -27.4% over the past six months.

But what now?

Do analysts rate it as a buy, sell or hold?

Regardless of recent performance, the main question is what the future holds. In uncertain economic conditions, it's often difficult to get an accurate view. The good news is that analysts generally have a solid understanding of the market's biggest businesses, so they are well-placed to make predictions. That shows up in their Buy, Hold and Sell recommendations.

Among the analysts covering Hutchmed (china), there are currently:

  • 1 Buy recommendations
  • 1 Hold recommendations
  • 0 Sell recommendations

With this kind of information, it's possible to start forming a view about the outlook for any share. A combination of recent price performance and analyst recommendations gives you a flavour of whether the market is expecting a bright future - or whether there are causes for concern.


What does this mean for potential investors?

HUTCHMED (China) is one of the most closely watched shares in the market. But while price trends and broker recommendations can give you an idea about the sentiment around a stock, they can't tell you everything. 

To get a better understanding of the overall investment case, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with HUTCHMED (China) that you can find out about here.


About us

Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.

HUTCHMED (China)'s StockRank™

Sucker StockSpeculative

HUTCHMED (China)'s StockRank™

With a StockRank of 13, HUTCHMED (China) is in the bottom 13% of the 7,639 stocks we cover in Europe, according to our proprietary ranking system.

See the full StockReport

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.